HARVARD BIOSCIENCE INC
For the period ended Mar 6, 2026. Filed Jan 30, 2026.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
Mar 6, 2026 · Filed Jan 30, 2026
Use the contents to explore the available documents and sections.
Contents
PROXY STATEMENT
_______________
Special Meeting of Stockholders to Be Held on March 6, 2026
This proxy statement is furnished in connection with the solicitation of proxies by the Board for use at the Special Meeting to be held on March 6, 2026, at 10:00 a.m. Eastern Time, and any adjournments or postponements thereof. The Special Meeting will be held by virtual meeting only. You will not be able to attend the Special Meeting in person.
To be admitted to the Special Meeting at www.virtualshareholdermeeting.com/HBIO2026SM, you must enter the control number found on your proxy card, voting instruction form or notice you previously received. You may vote during the Special Meeting by following the instructions available on the meeting website during the meeting. At the Special Meeting, the stockholders of the Company will be asked to consider and vote upon:
| 1. | A proposed amendment to the Harvard Bioscience, Inc. Second Amended and Restated Certificate of Incorporation, as amended, to effect a reverse stock split of our issued and outstanding shares of common stock, at a ratio of between 1-for-5 and 1-for-15; and |
| 2. | An authorization of an adjournment of the Special Meeting, if necessary, if a quorum is present, to solicit additional proxies if there are not sufficient votes in favor of Proposal 1. |
On or about January 30, 2026, we will mail to our stockholders the Notice containing instructions on how to access our proxy statement and how to vote.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.